Article View: bionet.software
Article #2358New Targets and Drug Modalities
From: James Prudhomme
Date: Tue, 19 Apr 2011 18:23
Date: Tue, 19 Apr 2011 18:23
52 lines
4279 bytes
4279 bytes
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities. The following presentations have just been added and are scheduled on Friday, June 10 from 1:30-3:50 p.m. Structure-Based Ligand Discovery for GPCRs Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego The Role of Recent Crystal Structures of Membrane Bound Proteins in Drug Discovery for CNS Targets Sid Topiol, Ph.D., CSO, Computational and Structural Investigations, 3D-2Drug Hitting a Moving Target: Characterizing GPCR Signaling through Long-timescale Molecular Dynamics Simulations Ron Dror, Ph.D., Senior Research Scientist and Special Advisor to the Chairman, D. E. Shaw Research Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of the D3R Selective Compounds Lei Shi, Ph.D., Assistant Professor, Department of Physiology and Biophysics, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College Moving in New Circles - Exploiting Macrocycles for Drug Discovery Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp. View full details and register at: http://www.healthtech.com/sbd or call 781-972-5400. Those that register by April 29 will receive the advanced registration discount. *** James Prudhomme Marketing Manager Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA 02494 Tel: 781-972-5486 Fax: 781-972-5425 www.healthtech.com
Technical Details
Message-ID:
<mailman.823.1303237666.20886.bio-soft@net.bio.net>Path:
arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: fa6b6,8cf438791b464d7e,start
X-Google-NewGroupId: yes
X-Google-Attributes: gid6710630482,domainid0,public,usenet
X-Google-Language: ENGLISH,ASCII-7-bit
Path: arc1-ca.pugleaf.net!g2news2.google.com!news2.google.com!Xl.tags.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!local2.nntp.dca.giganews.com!news.giganews.com.POSTED!not-for-mail
NNTP-Posting-Date: Tue, 19 Apr 2011 13:28:14 -0500
X-Envelope-From: jprudhomme@healthtech.com
From: "James Prudhomme" <jprudhomme@healthtech.com>
To: <Bio-soft@magpie.bio.indiana.edu>
Date: Tue, 19 Apr 2011 14:23:30 -0400
MIME-Version: 1.0
X-Mailer: Microsoft Office Outlook 12.0
Thread-Index: Acv+vuFIqQK3A3BkRaKmmwAHSRQp6A==
Content-Language: en-us
x-cr-hashedpuzzle: AgrN AhDI Bgz9 BzSw CJ2+ DYLc D5FL FByY FYMF GAIC Gyzg G7yq
HqZK HxXy IN7W KP7P; 1;
YgBpAG8ALQBzAG8AZgB0AEAAbgBlAHQALgBiAGkAbwAuAG4AZQB0AA==;
Sosha1_v1; 7; {1F2D3C97-774B-42B6-9AD2-93A901FD1A5B};
agBwAHIAdQBkAGgAbwBtAG0AZQBAAGgAZQBhAGwAdABoAHQAZQBjAGgALgBjAG8AbQA=;
Tue, 19 Apr 2011 18:23:28 GMT;
TgBlAHcAIABUAGEAcgBnAGUAdABzACAAYQBuAGQAIABEAHIAdQBnACAATQBvAGQAYQBsAGkAdABpAGUAcwA=
x-cr-puzzleid: {1F2D3C97-774B-42B6-9AD2-93A901FD1A5B}
X-Originating-IP: [66.228.71.161]
X-AntiSpam: Checked for restricted content by Gordano's AntiSpam Software
X-Mailman-Approved-At: Tue, 19 Apr 2011 13:27:44 -0500
Content-Type: text/plain;
charset="us-ascii"
Content-Transfer-Encoding: 7bit
X-Content-Filtered-By: Mailman/MimeDel 2.1.4
X-BeenThere: bio-soft@net.bio.net
X-Mailman-Version: 2.1.4
Precedence: list
Organization: BIOSCI/IUBio, Biology Dept., Indiana University
subject: New Targets and Drug Modalities
Newsgroups: bionet.software
Message-ID: <mailman.823.1303237666.20886.bio-soft@net.bio.net>
Approved: BIOSCI Approval Key <biosci-approval-key@net.bio.net>
X-Auth: PGPMoose V1.1 PGP bionet.software
iQCVAwUBTa3UI6CIqsWvyF5FAQGkGAQAoE+zYevtE2M+5OcVWohhRnwBF0Jtmdq/
6FaM2zy+N4tOLkSoJhZRlI+81xw28hiusrg9NeMBSe7fHnIz3Kd38k+ZkCyT6nIQ
SIkM9DHNQ9gc0O1nUV1VxDw7u4D8qzje8j8Ea+0X61HTuUh3ghEWqMtB8v9CST6i
uos/uEyv6Yk= =Vusu
Lines: 53
X-Usenet-Provider: http://www.giganews.com
X-Trace: sv3-hkAXx9z+mxxVh3a+ZVNc+ohPgLPOv9Awcu16YDZeE5/bFy0TyIqhKsa3SkslRjlk2tjgqC+84RIGPPx!F18VEQDKmjijW/3naoH08x+Ced+XShZ5vwaHX3hiofYDVLJwpPbZZczQZxKJ6c5wCzkQ+L2DO8mo!WO9kSg==
X-Complaints-To: abuse@giganews.com
X-DMCA-Notifications: http://www.giganews.com/info/dmca.html
X-Abuse-and-DMCA-Info: Please be sure to forward a copy of ALL headers
X-Abuse-and-DMCA-Info: Otherwise we will be unable to process your complaint properly
X-Postfilter: 1.3.40
X-Original-Bytes: 3983